Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC

Programmed cell death-1 (PD-1)/programmed death-ligand 1 (PD-L1) is an important pair of immune checkpoints (IC), which play an essential role in the immune escaping process of tumors. Anti-PD-1/PD-L1 immunotherapy can block the suppression effect of the immune system produced by tumor cells through...

Descripción completa

Detalles Bibliográficos
Autores principales: Bie, Fenglong, Tian, He, Sun, Nan, Zang, Ruochuan, Zhang, Moyan, Song, Peng, Liu, Lei, Peng, Yue, Bai, Guangyu, Zhou, Bolun, Gao, Shugeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863729/
https://www.ncbi.nlm.nih.gov/pubmed/35223466
http://dx.doi.org/10.3389/fonc.2022.769124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863729/
https://www.ncbi.nlm.nih.gov/pubmed/35223466
http://dx.doi.org/10.3389/fonc.2022.769124

Ejemplares similares